OptiBiotix Health (LON:OPTI – Get Free Report) announced its quarterly earnings data on Thursday. The company reported GBX (1.52) EPS for the quarter, Digital Look Earnings reports. OptiBiotix Health had a negative net margin of 332.69% and a negative return on equity of 77.85%.
OptiBiotix Health Price Performance
Shares of OptiBiotix Health stock opened at GBX 5.95 on Friday. OptiBiotix Health has a 12-month low of GBX 4.50 and a 12-month high of GBX 12.25. The firm has a market capitalization of £6.15 million, a PE ratio of -1.55 and a beta of 1.82. The stock’s fifty day moving average is GBX 5.78 and its 200-day moving average is GBX 5.74.
About OptiBiotix Health
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements. More than twenty international food and healthcare supplement companies have signed agreements with OptiBiotix to incorporate their human microbiome modulators into a wide range of food products and drinks.
OptiBiotix is also developing its own range of consumer supplements and health products.
Further Reading
- Five stocks we like better than OptiBiotix Health
- MarketBeat Week in Review – 09/14 – 09/18
- J.B. Hunt’s Stock Plunges After Market Misprices Profit Warning
- 2 Stocks Breaking Out Post-FOMC With One Thing in Common
- Lennar’s Q3 Miss Hides a Stronger Operating Story Beneath the Housing Slump
Receive News & Ratings for OptiBiotix Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health and related companies with MarketBeat.com's FREE daily email newsletter.
